Dyspepsia is a clinical condition in which the digestive capacity of the body is impaired causing various symptoms such as bloating, belching, nausea, and burning sensation in the chest. The two types of dyspepsia are: functional and undifferentiated. Functional dyspepsia occurs without any strong evidence of disease and is likely to affect approximately 15% of the general population in the U.S. and Europe. Undifferentiated dyspepsia can be caused due to peptic ulcer disease of stomach or duodenum. It may also be caused due to gastritis and gastro esophageal reflux disorder (GERD). The symptoms of dyspepsia are more common after 55 years of age.
The global dyspepsia market can be segmented based on type, end-user, and region. In terms of type, the market can be categorized into organic and functional. Organic causes of dyspepsia are esophageal cancer, pancreatic disorders, peptic ulcers, other infectious diseases, intolerance to drugs and foods, etc.
Indefinite organic cause can be determined in around 70% of the patients suffering from dyspepsia and this condition is termed as non-ulcer or functional dyspepsia. Diagnosis of this condition can be confirmed with the presence of epigastralgia for a period of more than six months. Majority of the patients who have dyspepsia suffer from functional dyspepsia and these patients have normal gut lining without any inflammation. This condition is common and can appear for no apparent reason. Some of the theories that have been proposed to be the most probable causes of this condition are delayed emptying of the stomach (stomach disorder) contents into duodenum, high acid sensitivity of the tissues lining duodenum and stomach, and infection with Helicobacter pylori bacterium can result in this condition as this bacterium can be detected in patients with non-ulcer dyspepsia
This disease may worsen and lead to severe symptoms such as upper abdominal pain, bloating sensation, unintentional weight loss, fullness, and occasionally palpitations. It may sometimes mask the symptoms of angina pain. Other conditions such as gastric malignancy, medication related ulceration, and other causes are ruled out prior to the treatment of dyspepsia.
The treatment options for dyspepsia include changes in dietary habits such as eating bland food, avoidance of spicy and oily food is advised by physicians. Food products such as chocolates, mint, and alcohol may worsen dyspepsia.
Medical drugs effective in the treatment of this disease include antacids such as Alka-Seltzer, Rolaids, Riopan, Maalox, and Mylanta. These are over-the-counter medicines and do not require prescriptions. Other drugs apart from antacids are H-2 receptors such as Tagament, Zantac, Axid, and Pepcid. Proton pump inhibitors are also administered for treatment of GERD and comprises brand drugs such as Nexium, Cipher, Prevacid, Protonix, Prilosec, and Zegerid. In cases of no identifiable cause, antidepressants have helped in reducing dyspeptic conditions such as nausea, headache, constipation, and night sweats.
In terms of end-user, the global dyspepsia market can be segmented into hospitals, diagnostic centers, academic and research institutes, and others. Geographically, the global dyspepsia market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the market, due to technological advancements, favorable reimbursement, and acceptance of minimally invasive techniques by the population.
Major pharmaceutical players such as Pfizer, GSK, Novartis, Thermo Fisher Scientific, Sanofi, Merck, and other generic players have strong presence in this market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.